Shelley Broader - Inspire Medical Director

2DR Stock  EUR 153.85  8.95  6.18%   

Insider

Shelley Broader is Director of Inspire Medical Systems since 2020.
Age 55
Tenure 5 years
Phone844 672 4357
Webhttps://www.inspiresleep.com

Shelley Broader Latest Insider Activity

Tracking and analyzing the buying and selling activities of Shelley Broader against Inspire Medical stock is an integral part of due diligence when investing in Inspire Medical. Shelley Broader insider activity provides valuable insight into whether Inspire Medical is net buyers or sellers over its current business cycle. Note, Inspire Medical insiders must abide by specific rules, including filing SEC forms every time they buy or sell Inspire Medical'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Inspire Medical Management Efficiency

The company has return on total asset (ROA) of (0.0692) % which means that it has lost $0.0692 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1238) %, meaning that it generated substantial loss on money invested by shareholders. Inspire Medical's management efficiency ratios could be used to measure how well Inspire Medical manages its routine affairs as well as how well it operates its assets and liabilities.
Inspire Medical Systems has accumulated 15.8 M in total debt with debt to equity ratio (D/E) of 0.14, which may suggest the company is not taking enough advantage from borrowing. Inspire Medical Systems has a current ratio of 13.16, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Inspire Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Inspire Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Inspire Medical Systems sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Inspire to invest in growth at high rates of return. When we think about Inspire Medical's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

BA BAPlatinum Investment Management
55
Greg JansenPerdoceo Education
48
Mei HooSemiconductor Manufacturing Int
59
BCom BCOMMLLBPlatinum Investment Management
N/A
Todd NelsonPerdoceo Education
64
Andrew HurstPerdoceo Education
60
Deborah SnyderPerdoceo Education
N/A
Michele PeppersPerdoceo Education
47
Xin ZhangSemiconductor Manufacturing Int
57
BMS BMSPlatinum Investment Management
55
BCOM BComPlatinum Investment Management
57
Guangli GuoSemiconductor Manufacturing Int
52
Andy BScPlatinum Investment Management
N/A
Virginia CarpenterPerdoceo Education
N/A
Wenyi ZhangSemiconductor Manufacturing Int
76
John KlinePerdoceo Education
60
Christina KlinePerdoceo Education
N/A
Tim KuoSemiconductor Manufacturing Int
N/A
Sam WangSemiconductor Manufacturing Int
N/A
Ashish GhiaPerdoceo Education
46
Toby BComPlatinum Investment Management
N/A
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea in the United States and Europe. Inspire Medical Systems, Inc. was incorporated in 2007 and is headquartered in Golden Valley, Minnesota. INSPIRE MED operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 341 people. Inspire Medical Systems (2DR) is traded on Frankfurt Exchange in Germany and employs 755 people.

Management Performance

Inspire Medical Systems Leadership Team

Elected by the shareholders, the Inspire Medical's board of directors comprises two types of representatives: Inspire Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Inspire. The board's role is to monitor Inspire Medical's management team and ensure that shareholders' interests are well served. Inspire Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Inspire Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Georgia GarinoisMelenikiotou, Director
Timothy Herbert, President, Chief Executive Officer, Director
Philip Ebeling, Chief Operating Officer
Steven Jandrich, Chief Compliance Officer, Vice President of Human Resources
Andreas Henke, VP Europe
Casey Tansey, Independent Director
Richard Buchholz, Chief Financial Officer
Mudit Jain, Independent Director
Chau Khuong, Independent Director
Martin Abrams, VP Experience
Gary Ellis, Independent Director
John Rondoni, Chief Officer
Shawn McCormick, Independent Director
Randall Ban, Chief Commercial Officer
Dana Mead, Independent Director
Shelley Broader, Director
Ivan Lubogo, Sr Sales
Marilyn Nelson, Independent Chairman of the Board
Jerry Griffin, Independent Director
Bryan Phillips, Senior Vice President Chief Compliance Officer, General Counsel, Company Secretary

Inspire Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Inspire Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in Inspire Stock

When determining whether Inspire Medical Systems is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Inspire Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Inspire Medical Systems Stock. Highlighted below are key reports to facilitate an investment decision about Inspire Medical Systems Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Inspire Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Please note, there is a significant difference between Inspire Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inspire Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inspire Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.